RUMORED BUZZ ON ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURERS

“The existing predicament has exposed some structural weaknesses inside the EU’s medicines offer chain in addition to a higher dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides said. She suggested that offer chain concerns be tackled within an EU pharmaceutical approach expected to get introduced by the top from